• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters1
367,316 results

Mallinckrodt Pharmaceuticals Ireland Limited et al v. Airgas Therapeutics LLC et al

Docket 1:22-cv-01648, Delaware District Court (Dec. 30, 2022)
Judge Richard G. Andrews, presiding, Judge Laura D. Hatcher
Patent - Abbreviated New Drug Application (ANDA)
DivisionWilmington
FlagsDISCOVERY-LDH, Multi-Media Docs, PATENT
Cause35:1 Patent Infringement
Case Type835 Patent - Abbreviated New Drug Application (ANDA)
Tags835 Patent, Abbreviated New Drug Application, Anda, 835 Patent, Abbreviated New Drug Application, Anda
DeadlineDispositive Motions due by 3/21/2025, Answering Briefs due by 4/18/2025, Reply Briefs due by 4/25/2025.
DeadlineORDER To Extend The Deadline For The Central Authority of Sweeden to execute the letter of requests to April 30, 2025..
Plaintiff Mallinckrodt Pharmaceuticals Ireland Limited
Plaintiff Mallinckrodt Hospital Products IP Unlimited Company
Plaintiff Mallinckrodt plc
...
cite Cite Docket
Analyze

Allergan, Inc. et al v. Revance Therapeutics, Inc. et al

Docket 1:21-cv-01411, Delaware District Court (Oct. 1, 2021)
Judge Richard G. Andrews, presiding, Judge Laura D. Hatcher
Patent
Log in to see more
cite Cite Docket
Analyze

No. 532 SO ORDERED Granting 531 STIPULATION and Proposed Order extending time to respond to the Court's ...

Document Allergan, Inc. et al v. Revance Therapeutics, Inc. et al, 1:21-cv-01411, No. 532 (D.Del. Feb. 14, 2025)
Motion to Extend TimeGranted
Log in to see more
cite Cite Document
Analyze

No. 346 MEMORANDUM OPINION

Document Mallinckrodt Pharmaceuticals Ireland Limited et al v. Airgas Therapeutics LLC et al, 1:22-cv-01648, No. 346 (D.Del. Feb. 12, 2025)
Log in to see more
cite Cite Document
Analyze

No. 526 ORDER ON MOTION TO SEAL: The motion to seal (D.I. 385 ) is GRANTED in part and DENIED in part

Document Allergan, Inc. et al v. Revance Therapeutics, Inc. et al, 1:21-cv-01411, No. 526 (D.Del. Feb. 12, 2025)
Motion to SealPartial
Log in to see more
cite Cite Document
Analyze

No. 480 ORDER: On December 20, 2024, Plaintiffs shall file a 20-page opening brief addressing the law ...

Document Allergan, Inc. et al v. Revance Therapeutics, Inc. et al, 1:21-cv-01411, No. 480 (D.Del. Dec. 16, 2024)
Log in to see more
cite Cite Document
Analyze

No. 478

Document Allergan, Inc. et al v. Revance Therapeutics, Inc. et al, 1:21-cv-01411, No. 478 (D.Del. Dec. 3, 2024)

cite Cite Document
Analyze

No. 476

Document Allergan, Inc. et al v. Revance Therapeutics, Inc. et al, 1:21-cv-01411, No. 476 (D.Del. Nov. 27, 2024)

cite Cite Document
Analyze
1 2 3 4 5 ... >>